Advertisement

Index by author

April 01, 1988; Volume 33,Issue 4

B

  1. Barhanin, J

    1. A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;

  2. Beck, W T

    1. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
      J M Zamora, H L Pearce and W T Beck
      Molecular Pharmacology April 1988, 33 (4) 454-462;

  3. Bhatnagar, R K

    1. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
      T K Chatterjee, C E Scott, D M Vazquez and R K Bhatnagar
      Molecular Pharmacology April 1988, 33 (4) 402-413;

  4. Binder, T P

    1. Sulfation of benzylic alcohols catalyzed by aryl sulfotransferase IV.
      T P Binder and M W Duffel
      Molecular Pharmacology April 1988, 33 (4) 477-479;

  5. Bottari, S P

    1. Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
      R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts
      Molecular Pharmacology April 1988, 33 (4) 389-395;

C

  1. Chatterjee, T K

    1. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
      T K Chatterjee, C E Scott, D M Vazquez and R K Bhatnagar
      Molecular Pharmacology April 1988, 33 (4) 402-413;

  2. Cowan, K H

    1. Modulation of a human dihydrofolate reductase minigene following release from amino acid deprivation involves both 5' and 3' nucleotide sequences.
      M E Goldsmith and K H Cowan
      Molecular Pharmacology April 1988, 33 (4) 378-383;

  3. Cox, B M

    1. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
      L L Werling, P S Puttfarcken and B M Cox
      Molecular Pharmacology April 1988, 33 (4) 423-431;

D

  1. Debing, I

    1. Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
      I Debing, A P Ijzerman and G Vauquelin
      Molecular Pharmacology April 1988, 33 (4) 470-476;

  2. De Matteis, F

    1. Role of iron in the hydrogen peroxide-dependent oxidation of hexahydroporphyrins (porphyrinogens): a possible mechanism for the exacerbation by iron of hepatic uroporphyria.
      F De Matteis
      Molecular Pharmacology April 1988, 33 (4) 463-469;

  3. Duffel, M W

    1. Sulfation of benzylic alcohols catalyzed by aryl sulfotransferase IV.
      T P Binder and M W Duffel
      Molecular Pharmacology April 1988, 33 (4) 477-479;

F

  1. Fisher, S K

    1. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
      S K Fisher
      Molecular Pharmacology April 1988, 33 (4) 414-422;

G

  1. Glazer, R I

    1. Association of p93c-fes tyrosine protein kinase with granulocytic/monocytic differentiation and resistance to differentiating agents in HL-60 leukemia cells.
      G Yu, S Grant and R I Glazer
      Molecular Pharmacology April 1988, 33 (4) 384-388;

  2. Goldberg, I H

    1. Role of epoxide in neocarzinostatin chromophore stability and action.
      S H Lee and I H Goldberg
      Molecular Pharmacology April 1988, 33 (4) 396-401;

  3. Goldfien, A

    1. Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
      R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts
      Molecular Pharmacology April 1988, 33 (4) 389-395;

  4. Goldsmith, M E

    1. Modulation of a human dihydrofolate reductase minigene following release from amino acid deprivation involves both 5' and 3' nucleotide sequences.
      M E Goldsmith and K H Cowan
      Molecular Pharmacology April 1988, 33 (4) 378-383;

  5. Grant, S

    1. Association of p93c-fes tyrosine protein kinase with granulocytic/monocytic differentiation and resistance to differentiating agents in HL-60 leukemia cells.
      G Yu, S Grant and R I Glazer
      Molecular Pharmacology April 1988, 33 (4) 384-388;

H

  1. Habberfield, A D

    1. Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.
      H G Joost, A D Habberfield, I A Simpson, A Laurenza and K B Seamon
      Molecular Pharmacology April 1988, 33 (4) 449-453;

  2. Henning, R

    1. A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;

I

  1. Ijzerman, A P

    1. Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
      I Debing, A P Ijzerman and G Vauquelin
      Molecular Pharmacology April 1988, 33 (4) 470-476;

J

  1. Jacobs, M M

    1. Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
      R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts
      Molecular Pharmacology April 1988, 33 (4) 389-395;

  2. Joost, H G

    1. Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.
      H G Joost, A D Habberfield, I A Simpson, A Laurenza and K B Seamon
      Molecular Pharmacology April 1988, 33 (4) 449-453;

L

  1. Laurenza, A

    1. Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.
      H G Joost, A D Habberfield, I A Simpson, A Laurenza and K B Seamon
      Molecular Pharmacology April 1988, 33 (4) 449-453;

  2. Lazdunski, M

    1. A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;

  3. Lee, S H

    1. Role of epoxide in neocarzinostatin chromophore stability and action.
      S H Lee and I H Goldberg
      Molecular Pharmacology April 1988, 33 (4) 396-401;

  4. Lerch, U

    1. A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;

M

  1. Marie, J

    1. Covalent labeling of vasopressin receptors from LLC-PK1 cells by the use of a bifunctional reagent.
      J Marie and C Roy
      Molecular Pharmacology April 1988, 33 (4) 432-440;

O

  1. Oekonomopulos, R

    1. A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;

P

  1. Parsons, W J

    1. The new cardiotonic agent sulmazole is an A1 adenosine receptor antagonist and functionally blocks the inhibitory regulator, Gi.
      W J Parsons, V Ramkumar and G L Stiles
      Molecular Pharmacology April 1988, 33 (4) 441-448;

  2. Pearce, H L

    1. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
      J M Zamora, H L Pearce and W T Beck
      Molecular Pharmacology April 1988, 33 (4) 454-462;

  3. Puttfarcken, P S

    1. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
      L L Werling, P S Puttfarcken and B M Cox
      Molecular Pharmacology April 1988, 33 (4) 423-431;

Q

  1. Qar, J

    1. A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;

R

  1. Ramkumar, V

    1. The new cardiotonic agent sulmazole is an A1 adenosine receptor antagonist and functionally blocks the inhibitory regulator, Gi.
      W J Parsons, V Ramkumar and G L Stiles
      Molecular Pharmacology April 1988, 33 (4) 441-448;

  2. Reisine, T

    1. Somatostatin receptor subtypes in the clonal anterior pituitary cell lines AtT-20 and GH3.
      K Thermos and T Reisine
      Molecular Pharmacology April 1988, 33 (4) 370-377;

  3. Riemer, R K

    1. Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
      R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts
      Molecular Pharmacology April 1988, 33 (4) 389-395;

  4. Roberts, J M

    1. Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
      R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts
      Molecular Pharmacology April 1988, 33 (4) 389-395;

  5. Romey, G

    1. A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;

  6. Roy, C

    1. Covalent labeling of vasopressin receptors from LLC-PK1 cells by the use of a bifunctional reagent.
      J Marie and C Roy
      Molecular Pharmacology April 1988, 33 (4) 432-440;

S

  1. Scott, C E

    1. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
      T K Chatterjee, C E Scott, D M Vazquez and R K Bhatnagar
      Molecular Pharmacology April 1988, 33 (4) 402-413;

  2. Seamon, K B

    1. Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.
      H G Joost, A D Habberfield, I A Simpson, A Laurenza and K B Seamon
      Molecular Pharmacology April 1988, 33 (4) 449-453;

  3. Simpson, I A

    1. Activation of adenylate cyclase and inhibition of glucose transport in rat adipocytes by forskolin analogues: structural determinants for distinct sites of action.
      H G Joost, A D Habberfield, I A Simpson, A Laurenza and K B Seamon
      Molecular Pharmacology April 1988, 33 (4) 449-453;

  4. Stiles, G L

    1. The new cardiotonic agent sulmazole is an A1 adenosine receptor antagonist and functionally blocks the inhibitory regulator, Gi.
      W J Parsons, V Ramkumar and G L Stiles
      Molecular Pharmacology April 1988, 33 (4) 441-448;

T

  1. Thermos, K

    1. Somatostatin receptor subtypes in the clonal anterior pituitary cell lines AtT-20 and GH3.
      K Thermos and T Reisine
      Molecular Pharmacology April 1988, 33 (4) 370-377;

U

  1. Urbach, H

    1. A novel high affinity class of Ca2+ channel blockers.
      J Qar, J Barhanin, G Romey, R Henning, U Lerch, R Oekonomopulos, H Urbach and M Lazdunski
      Molecular Pharmacology April 1988, 33 (4) 363-369;

V

  1. Vauquelin, G

    1. Melanosome binding and oxidation-reduction properties of synthetic L-dopa-melanin as in vitro tests for drug toxicity.
      I Debing, A P Ijzerman and G Vauquelin
      Molecular Pharmacology April 1988, 33 (4) 470-476;

  2. Vazquez, D M

    1. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
      T K Chatterjee, C E Scott, D M Vazquez and R K Bhatnagar
      Molecular Pharmacology April 1988, 33 (4) 402-413;

W

  1. Werling, L L

    1. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
      L L Werling, P S Puttfarcken and B M Cox
      Molecular Pharmacology April 1988, 33 (4) 423-431;

  2. Wu, Y Y

    1. Estrogen reduces beta-adrenoceptor-mediated cAMP production and the concentration of the guanyl nucleotide-regulatory protein, Gs, in rabbit myometrium.
      R K Riemer, Y Y Wu, S P Bottari, M M Jacobs, A Goldfien and J M Roberts
      Molecular Pharmacology April 1988, 33 (4) 389-395;

Y

  1. Yu, G

    1. Association of p93c-fes tyrosine protein kinase with granulocytic/monocytic differentiation and resistance to differentiating agents in HL-60 leukemia cells.
      G Yu, S Grant and R I Glazer
      Molecular Pharmacology April 1988, 33 (4) 384-388;

Z

  1. Zamora, J M

    1. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells.
      J M Zamora, H L Pearce and W T Beck
      Molecular Pharmacology April 1988, 33 (4) 454-462;
Back to top

In this issue

Advertisement